Oval Medical raises cash, reports positive study results

Oval Medical Technologies, a medical device start-up based in the U.K., has raised another stack of cash and announced positive results for a trial that compares its novel autoinjector with two well-known devices already on the market. According to the company, several large drugmakers have shown "substantial interest" in working with Oval and are undertaking feasibility studies to assess using the company's technology for a variety of injectable drugs, Ben Fountain of Cabume reports. Story

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.